SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange - Prism Media Wire
Phoenix, AZ, December 18, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable solar energy and sustainable solutions provider participated in the iconic opening bell ringing ceremony, Friday December 15th, 2023. The event marked the successful listing of the Company’s common stock on the Cboe BZX Exchange. “It was a pleasure to initiate
Read More
MindMed Advances Treatment for Generalized Anxiety Disorder
MindMed Advances Treatment for Generalized Anxiety Disorder - Prism Media Wire
NEW YORK, NY, December 18, 2023 - Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). The trial met its primary endpoint, with MM-120 demonstrating statistically significant and clinically meaningful dose-dependent improvements. Robert Barrow, Chief Executive Officer and Director of MindMed, said, “We
Read More
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday? - Prism Media Wire
NEW YORK, NY, December 18, 2023 - Shares in Battalion Oil Corporation (NYSE American: BATL) surged more than 80% on Friday after the company announced it has agreed to be acquired by Fury Resources, Inc. for $9.80 per share in cash, which represents a total transaction value of approximately $450 million. The transaction is expected to close in the
Read More
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors - Prism Media Wire
POMPANO BEACH, FLORIDA, December 19, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed Mr. Patrick Daly to its Board of Directors. Mr. Daly is an award-winning executive leader with a strong track
Read More
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts
PPJ Healthcare Enterprises, Inc. signed new Billing Accounts - Prism Media Wire
TAMPA, FLORIDA, December 19, 2023 - PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced today that it closed one billing agreement with a ‘pain management physicians’ group to provide their billing and collections. “We have been successful in providing specialty billing services for over 33 years, and we are very excited to add this
Read More
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split - Prism Media Wire
Phoenix, AZ, December 19, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better health and living, today announced the closing of its underwritten public offering of 800,000 shares of common stock at a public offering
Read More
NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment
NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment - Prism Media Wire
New York, December 19, 2023 - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary Tract infections (cUTI). The company’s shares surged 25% in trading on Monday following the news. Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens
Read More
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished - Prism Media Wire
-Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company") a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity. Based in Pittsburgh, PA, the Company has made substantial strides over the past year, achieving critical
Read More
Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership
Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership - Prism Media Wire
New York, December 20, 2023 - Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more than 15% on Tuesday after the company announced it would expand its partnership with Walmart to offer a Buy Now, Pay Later (BNPL) service at self-checkout kiosks at over 4,500 Walmart stores in the United States. Pat Suh, Affirm’s SVP of Revenue,
Read More
Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control
Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control - Prism Media Wire
Spooz Acquired Key JP Energy Assets; Vests Control to John K. Park Clearwater, FL., December 20, 2023 -- Spooz, Inc. (OTC: SPZI) completed the acquisition of key JP Energy assets for vesting control of Spooz, Inc. to John K. Park. Additional assets to be announced later in exchange for vesting control of Spooz, Inc. to
Read More
PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success
PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success - Prism Media Wire
New York, December 20, 2023 - Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of strategic accomplishments on its first anniversary as a public company. Lipella is advancing three clinical indications and has been granted two Orphan Drug Designations by the US Food and Drug Administration (FDA). Today, the company announced it has successfully completed a
Read More
PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%
PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120% - Prism Media Wire
New York, December 20, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights Panbela Therapeutics, Inc. which has announced that US WorldMeds®1 (USWM) has received FDA approval of its New Drug Application (NDA) for the use of eflornithine as a maintenance therapy for high-risk neuroblastoma patients. In July 2023, Panbela divested
Read More
Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com
Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com - Prism Media Wire
LOS ANGELES, December 21, 2023 - Clubhouse Media Group, Inc. (OTC: CMGR) ("CMGR"), a social media firm, today announced that it has terminated its joint venture agreement with The Reiman Agency so that the company can dedicate its time and resources to the development and continued growth of HoneyDrip.com. Honeydrip.com is a digital platform designed
Read More
Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial
Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial - Prism Media Wire
New York, December 21, 2023 - Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct a phase 1/2 clinical trial using the company’s innovative StemSpine® treatment known as AlloStem™ (CELZ-201-DDT). Timothy Warbington, CEO of Creative Medical Technology, said, “The FDA’s clearance and IRB approval allowing us to pursue this clinical trial is another milestone event for
Read More
SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange
SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange - Prism Media Wire
Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30 million Completed $4,000,000 Underwritten Offering Capital Raise Phoenix, AZ, December 21, 2023 - SinglePoint Inc. (Cboe: SING) a leading renewable solar energy and sustainable solutions provider releases shareholder letter overviewing 2023 and Successful listing on Cboe BZX Exchange. Dear Shareholders, As
Read More
Palatin Technologies Sells Vyleesi in $171M Transaction
Palatin Technologies Sells Vyleesi in $171M Transaction - Prism Media Wire
New York, December 21, 2023 - Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to Cosette Pharmaceuticals, a US-based, specialty pharmaceutical company, for up to $171 million. Vyleesi is the first and only as-needed FDA-approved treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). Carl Spana, Ph.D., President and Chief Executive Officer
Read More
Spooz, Inc. (SPZI) / JP Energy / John K. Park – announce Shareholder Letter
Spooz, Inc. (SPZI) / JP Energy / John K. Park – announce Shareholder Letter - Prism Media Wire
Clearwater, FL., December 21, 2023 -- Spooz, Inc. (OTC: SPZI) announces the release of the following shareholder letter: Dear Spooz Shareholder, By now, you are aware that I recently became the Chairman and CEO of Spooz. I am a 63-year-old Korean businessman and a US Citizen. I received my MBA from Rutgers University 24 years ago
Read More
Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start
Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start - Prism Media Wire
New York, December 21, 2023 - In two weeks, 2023 will be history so consider this your reminder to start figuring out a resolution that likely will be forgotten, by this time next year. New Years is celebrated in a multitude of ways based on geography, culture, or religion. However, unlike other holidays, it is
Read More
PRISM Analysis: Why Did CareCloud Shares Jump This Week?
PRISM Analysis: Why Did CareCloud Shares Jump This Week? - Prism Media Wire
New York, December 22, 2023 - Healthcare technology solutions provider, CareCloud, Inc. (Nasdaq: CCLD) has seen a jump in its share price this week. The new momentum is being driven by the company’s financial and operational update, issued on Wednesday, and outlining an attractive roadmap for future growth. Shareholders rewarded CareCloud with a 25.61% increase following Wednesday’s session, and
Read More
PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40% - Prism Media Wire
New York, December 22, 2023 - PetVivo Holdings, Inc. (Nasdaq: PETV) has achieved a distribution milestone, reporting a total of 4500 syringes of Spryng™ with OsteoCushion™ technology distributed to veterinarians in the 2023 calendar year. Spryng, the company’s signature product, helps to manage lameness, joint pain and osteoarthritis in horses and small animals. Earlier this month, the company announced the sale
Read More
HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment - Prism Media Wire
New York, December 22, 2023 - Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK), common stock for approximately $21.25 million, at a price of $1.4167 per share. Under the agreement, HOOKIPA is responsible for advancing its HIV program through the completion of a Phase 1b clinical trial. The company’s shares rose 52.65% on Thursday
Read More